Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Down 11.4% in December

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 2,119,600 shares, a decrease of 11.4% from the November 30th total of 2,393,200 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Genomma Lab Internacional Stock Performance

Shares of GNMLF stock remained flat at $1.27 on Wednesday. The business has a 50-day simple moving average of $1.23 and a 200 day simple moving average of $1.10. Genomma Lab Internacional has a 52-week low of $0.79 and a 52-week high of $1.28.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.